Gene Therapy
Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.
131 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 26 |
Goldman Sachs
New York
| $303M | -$50.8M | 33 | 0.09% | Reduced |
|
| 27 |
JP Morgan Chase
New York
| $301M | +$55.5M | 21 | 0.07% | Increased |
|
| 28 |
Renaissance Technologies
New York
| $281M | -$17.4M | 20 | 0.44% | Reduced |
|
| 29 |
Invesco
Atlanta,
Georgia
| $277M | -$17.3M | 11 | 0.09% | Reduced |
|
| 30 |
Morgan Stanley
New York
| $273M | +$19.2M | 42 | 0.09% | Increased |
|
| 31 |
Bank of New York Mellon
New York
| $249M | +$3.99M | 33 | 0.07% | Increased |
|
| 32 |
Federated Hermes
Pittsburgh,
Pennsylvania
| $246M | +$111M | 7 | 0.74% | Increased |
|
| 33 |
Janus Henderson Investors US
Denver,
Colorado
| $235M | -$7.11M | 4 | 0.2% | Reduced |
|
| 34 |
Mawer Investment Management
Calgary,
Alberta, Canada
| $221M | -$59.4M | 1 | 2.26% | Reduced |
|
| 35 |
Thomaspartners
Boston,
Massachusetts
| $220M | +$17.6M | 1 | 2.38% | Increased |
|
| 36 |
EARNEST Partners
Atlanta,
Georgia
| $218M | +$19.8M | 4 | 2.38% | Increased |
|
| 37 |
Aristotle Capital Management
Los Angeles,
California
| $201M | +$3.26M | 1 | 1.9% | Increased |
|
| 38 |
Norges Bank
Oslo,
Norway
| $186M | +$7.52M | 12 | 0.08% | Increased |
|
| 39 |
Dimensional Fund Advisors
Austin,
Texas
| $183M | +$1.9M | 14 | 0.09% | Increased |
|
| 40 |
1832 Asset Management
Toronto,
Ontario, Canada
| $180M | +$180M | 1 | 0.55% | Increased |
|
| 41 |
Lazard Asset Management
New York
| $179M | -$2.75M | 4 | 0.37% | Reduced |
|
| 42 |
Capital International Investors
Los Angeles,
California
| $177M | +$36.9M | 2 | 0.26% | Increased |
|
| 43 |
Ameriprise
Minneapolis,
Minnesota
| $173M | -$27M | 10 | 0.09% | Reduced |
|
| 44 |
SCCM
Schafer Cullen Capital Management
New York
| $170M | +$66.8M | 1 | 2.31% | Increased |
|
| 45 |
Millennium Management
New York
| $169M | -$77.6M | 25 | 0.35% | Reduced |
|
| 46 |
Capital World Investors
Los Angeles,
California
| $161M | -$44.6M | 3 | 0.04% | Reduced |
|
| 47 |
Royal Bank of Canada
Toronto,
Ontario, Canada
| $155M | +$21.5M | 30 | 0.08% | Increased |
|
| 48 |
OrbiMed
New York
| $146M | -$131M | 11 | 1.86% | Reduced |
|
| 49 |
UBS AM
Chicago,
Illinois
| $143M | -$13.4M | 9 | 0.16% | Reduced |
|
| 50 |
Geode Capital Management
Boston,
Massachusetts
| $141M | +$12.8M | 42 | 0.07% | Increased |
|